New Lyme disease treatment kills bacteria that causes lingering symptoms
A new Stanford Medicine study provides evidence that the drug azlocillin could be effective for treating Lyme disease patients infected with drug-tolerant bacteria.
A new Stanford Medicine study provides evidence that the drug azlocillin could be effective for treating Lyme disease patients infected with drug-tolerant bacteria.
A man from London has become the second person in the world to be cured of HIV, doctors say. Adam Castillejo is still free of the virus more than 30 months after stopping anti-retroviral therapy.
The plan will be phased in with first-year students entering the university in fall 2020. Additionally, the university’s financial need calculations will no longer consider home ownership.
The drug works in a different way to existing antibacterials and is the first of its kind to be found by setting AI loose on vast digital libraries of pharmaceutical compounds.
Scientists at the University of Massachusetts Amherst have designed a device that uses a natural protein to create electricity from moisture in the air.
The approach was demonstrated in mice at the University of Michigan, with the nanoparticles enhancing healing by reprogramming the aggressive immune cells—call it an “EpiPen” for trauma to the central nervous system.
AI could reduce costs of labor and R&D of pharmaceuticals by 80%. The front-loaded savings means that more drugs for more diseases can be synthesized and moved into trials.
The City University of Hong Kong researchers say that a single rain droplet can briefly generate 140 volts, enough to briefly power 100 small lightbulbs.
Scientists for the first time have developed a single molecule that can absorb sunlight efficiently and act as a catalyst to transform solar energy into hydrogen, a clean alternative to fossil fuels.
Seventy-eight of the U.K.’s 154 public universities have joined the divestment campaign, either divesting or pledging to divest hundreds of millions from the fossil fuel industry.